Beginning in January 2022, András Komáromy, DrMedVet, PhD, DACVO, DECVO, will begin work as the editor-in-chief of Veterinary Ophthalmology, an international, peer-reviewed research journal that covers clinical and comparative ophthalmology, naturally occurring ocular disease, veterinary models of both human and animal eye disease, and anatomic, physiological, and pharmacological studies of the animal eye.
Initially, Komáromy will work together with Dr. David Wilkie, current editor and professor emeritus from The Ohio State University’s College of Veterinary Medicine, to share duties and work together until the editorial transition is complete later in the year.
“It is a great honor to be appointed as the third Editor-in-Chief for the Journal following Dr. David Wilkie and the founding editor-in-chief, my former mentor Dr. Kirk Gelatt, Distinguished Professor Emeritus at the University of Florida. With the support of an international and diverse Editorial Board, I am committed to preserving and further developing Veterinary Ophthalmology as the primary journal for all articles pertaining to veterinary and comparative ophthalmology worldwide," says Komáromy.
Komáromy is a professor and clinician-scientist for the MSU College of Veterinary Medicine’s Department of Small Animal Clinical Sciences. Since 2012, the Komáromy Laboratory has worked to determine the molecular causes of inherited retinal and optic nerve diseases in dogs, and developed treatment approaches to improve sight degeneration. Together with collaborators, he developed promising gene therapies for day and color blindness (achromatopsia) and glaucoma. Currently, his laboratory focuses on the development of novel and improved treatments for glaucoma, a leading cause of irreversible blindness in humans and dogs. Komáromy’s research is supported by the National Institutes of Health, various foundations, and private industry.
To learn more about Komáromy's research, see PubMed.